Abstract:What's New? Radiotherapy for breast cancer has been associated with an increased risk of subsequent primary lung cancer. Whether this association varies by histological subtype of lung cancer remains unknown. Using high‐quality cancer registry data, this study found that the increased lung cancer risk associated with radiotherapy is confined to ipsilateral small‐cell and squamous cell carcinoma occurring at least five years after breast cancer diagnosis. The findings suggest distinct carcinogenic pathways of radiation‐induced lung cancer across histological subtypes and may inform risk‐stratified surveillance guidelines. Advancements in radiotherapy could potentially reduce the risks of developing aggressive forms of lung cancer. Radiotherapy for breast cancer has been associated with an increased risk of secondary malignancies, including primary lung cancer. Whether this association varies by histological subtype of lung cancer remains unknown. Based on the data from 12 Surveillance, Epidemiology, and End Results registries, we examined the association between radiotherapy receipt and the risk of subtype‐specific subsequent primary lung cancer (SPLC) among female first primary breast cancer cases diagnosed between ages 20 and 84 from 1992 to 2020. More than half (53%) of the 550,007 breast cancer survivors identified had undergone radiotherapy as part of their initial breast cancer treatment. Over an average follow‐up of 9.7 years, 8014 survivors developed SPLCs. For small‐cell carcinoma, the standardized incidence ratio (SIR) compared with the general population was higher for survivors who received radiotherapy (SIR = 1.15, 95% confidence interval [CI] = 1.06–1.25) but similar for those who did not receive radiotherapy (SIR = 1.00, 95% CI = 0.91–1.09), with the difference in SIRs being statistically significant (p = .003). Similar associations were found for squamous cell carcinoma (SIRyes = 1.16, 95% CI = 1.08–1.24 vs. SIRno/unknown = 1.06, 95% CI = 0.98–1.15; p = .07). The increased risks were confined to ipsilateral SPLC, with the greatest SIRs for small‐cell carcinoma occurring 5–10 years since breast cancer diagnosis (SIR = 1.83, 95% CI = 1.53–2.19) and for squamous cell carcinoma with a latency of 10 years or more (SIR = 1.64, 95% CI = 1.42–1.88). In contrast, the risk of developing adenocarcinoma did not vary by radiotherapy receipt (SIRyes = 1.23, 95% CI = 1.18–1.28 vs. SIRno/unknown = 1.17, 95% CI = 1.12–1.22; p = .18), indicating additional risk factors in play. The findings suggest a distinct carcinogenic pathway of radiation‐induced lung cancer across histological subtypes and may inform risk‐stratified surveillance guidelines for SPLC.

The Impact of Radiotherapy on the Incidence of Secondary Malignancies: A Pan-Cancer Study in the US SEER Cancer Registries

Association between radiotherapy and the risk of second primary malignancies in breast cancer patients with different estrogen receptor statuses

Association Between Radiotherapy and Non-Gastric Second Primary Malignancies in Patients with Resectable Gastric Cancer : A Propensity-Adjusted, Population-Based SEER Analysis

Association Between Radiotherapy and Risk of Second Primary Malignancies in Patients with Resectable Lung Cancer: a Population-Based Study

Radiotherapy and Increased Risk of Second Primary Cancers in Breast Cancer Survivors: an Epidemiological and Large Cohort Study

Radiotherapy of prostate cancer: impact of treatment characteristics on the incidence of second tumors

Risk of Second Primary Cancers among Long-Term Survivors of Breast Cancer

Incidence and associated factors of developing second pelvic malignant neoplasms among prostate cancer patients treated with radiotherapy

Radiation Therapy Changed the Second Malignancy Pattern in Rectal Cancer Survivors.

Association Between Postoperative Radiotherapy for Young-Onset Nonsmall Cell Lung Cancer and Risk of Second Primary Malignancies: Comparative Study

Palliative beam radiotherapy offered real-world survival benefit to metastatic rectal cancer: A large US population-based and propensity score-matched study.

Impact of radiotherapy on second primary lung cancer incidence and survival in esophageal cancer survivors

A retrospective study on the impact of radiotherapy on the survival outcomes of small cell lung cancer patients based on the SEER database

The risk and latency evaluation of secondary primary malignancies of cervical cancer patients who received radiotherapy: A study based on the SEER database

98PEffect of postmastectomy radiotherapy on breast cancer with isolated tumor cells or micrometastases in regional lymph nodes: A propensity score matched analysis using the SEER database

Associations of radiotherapy receipt with lung cancer risk by histological subtype among breast cancer survivors in the United States

Risk Factors and Specific Cancer Types of Second Primary Malignancies in Patients with Breast Cancer Receiving Adjuvant Radiotherapy: a Case-Control Cohort Study Based on the SEER Database.

Risk and Prognosis of Secondary Malignant Neoplasms after Radiation Therapy for Bladder Cancer: A Large Population-Based Cohort Study

Effectiveness and risk of second primary malignancies after radiotherapy in major salivary gland carcinomas: A retrospective study using SEER database

The impact of baseline health factors on second primary cancer risk after radiotherapy for prostate cancer

Association between radiation therapy for primary endometrial cancer and risk of second primary malignancies: a retrospective cohort study